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Abstract
Fatal infectious disease acquired during international travel is less likely to be captured through 
existing surveillance when diagnosis is delayed or missed, especially as autopsy rates decline. 
Death of a young girl owing to malaria demonstrates needs for increased examination of travel-
related deaths through postmortem investigation, autopsy, and expanded surveillance.
Malaria, a mosquito-borne parasitic infection, is one of the most common causes of systemic 
febrile illness in travelers.1 In the United States, approximately 1,500 cases of malaria are 
reported to the Centers for Disease Control and Prevention (CDC) each year, virtually all of 
which are imported from endemic countries via travelers.2 While surveillance system data 
have indicated that infectious diseases account for only a small number of travel-related 
American deaths,3,4 ill recent travelers who are not diagnosed will not be identified as 
having an infectious disease-related illness. This is of particular concern for illnesses that 
result in death in an era when autopsies are becoming uncommon.
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In May 2011, a 4-year-old girl and her mother returned to the United States after having 
spent more than 3 weeks visiting family in Uganda, a country where travelers are at high 
risk for acquiring malaria; neither had taken malaria chemoprophylaxis. While in Uganda, 
the girl became ill with fever and cough and presented to a clinic for treatment. Diarrhea and 
vomiting were reported; rash and bleeding were denied and no chronic conditions were 
reported. The girl was diagnosed with a bacterial infection and given acetaminophen 
suppositories and unspecified antibiotics. Care for the girl was sought six more times over a 
2-week period with continued signs and symptoms. Malaria was reportedly tested for but not 
diagnosed. High fever was still reported, and the decision was made to return to the United 
States.
On the return flight to the United States, the girl was very thirsty and drank a large amount 
of liquid without subsequently urinating either on the plane or in the terminal upon landing. 
While on a layover at Dulles International Airport (Dulles, VA), she became unresponsive. 
She was pronounced dead at a hospital an hour later.
Her body was transferred to the Virginia Department of Health Office of the Chief Medical 
Examiner to perform an autopsy, as required by Virginia law in cases of sudden unexpected 
death.
On autopsy, she was normally developed and nourished but appeared ill and dehydrated. She 
had scabbed lesions on the left side of her face and left calf that were consistent with 
mosquito bites. The internal examination was nonspecific with congestion and edema in 
various organs and generalized lymphadenopathy. There was no significant trauma, 
congenital anomaly, or discrete source of infection to cause her death. Elevated urea 
nitrogen and creatinine consistent with kidney failure were detected in vitreous sample. 
Tissues, including brain, heart, liver, and kidney, were submitted to CDC for consultation. 
Histopathology revealed characteristic intra-erythrocyte parasites suggestive of Plasmodium 
species. Immunohistochemistry and polymerase chain reaction assays of autopsy tissues and 
serum confirmed infection with Plasmodium falciparum.
Discussion
Fatal malaria in this child who did not receive chemoprophylaxis or adequate diagnosis and 
treatment again illustrates the danger of acquiring malaria during travel. Because of the 
patient’s sudden death outside a health care facility, an autopsy was performed and a true 
cause of death was established. However, other travelers returning from abroad who become 
ill or expire may be examined without regard to travel status.5 Death may occur after a 
latency period,6 and travel status may not be considered as a part of the cause of death. This 
might be especially true if the patient was found dead or was too ill to provide details on 
recent travel. There may be other cases where a true cause of death cannot be established 
because a postmortem examination was not performed.
To better inform travelers and the clinicians who provide medical advice to persons before 
and after travel, it is important to understand factors associated with travel-associated severe 
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illness. Surveillance systems cannot acquire the needed information to better learn from and 
prevent severe travel-associated illness if the illness is not identified or reported, and illness 
in patients who die before diagnosis might represent an important gap in our knowledge of 
these illnesses.
GeoSentinel, a worldwide travel-related illness surveillance system, is one of the largest 
sources of information about illnesses acquired by travelers. GeoSentinel data reported by 
Freedman and colleagues identified fewer than 20 deaths between 1996 and 2004.1 
Systematic data are collected at GeoSentinel surveillance sites, often travel medicine 
clinics,7 as part of post-travel visits, but the system is unable to capture data on returning 
travelers who present to an emergency room or primary care provider rather than a travel 
medicine clinic with severe illness, especially in the United States. Lawson and colleagues 
reported that based on 3 years of data captured by the Quarantine Activity and Reporting 
System (QARS), vaccine-preventable and tropical diseases are not major causes of death in 
international travelers arriving in the United States.4 Because malaria is not a communicable 
disease spread person-to-person, reports of malaria are not requested by CDC Quarantine 
Stations. Only deaths that occurred during travel (on a conveyance or at a US port of entry) 
are requested. Thus, QARS did not capture 12 malaria deaths associated with international 
travel reported by the US National Malaria Surveillance System during that same time 
period.2 While QARS is capable of collecting travel-related illnesses or deaths, it would not 
be an effective surveillance system for travel-associated mortality due to malaria.
The cause of death for travelers who died during travel or upon returning from travel might 
be captured on the US Standard Certificate of Death.8 However, only the travel-associated 
data recorded on the death certificate relate to fatal travel-related injury. As a result, data on 
returning travelers who died as a result of travel-related illness will not be captured 
systematically by the current version of the US death certificate for inclusion in US vital 
statistics data. The risks related to travel may not even be considered in assigning cause of 
death, especially if the signs and symptoms of disease were not overtly suggestive of a 
specific travel-related illness, such as malaria or rickettsia, whose symptoms may be shared 
with many other less exotic maladies.
While travel-related information is obtained from ill patients who are able to provide it, the 
value of a travel history collected by a physician is often limited to its use in diagnosis and 
treatment. Travel histories collected in a clinical setting for treatment are often not collected 
at all or are incomplete,9 which can limit a systematic collection of epidemiologic data 
related to severe travel-related illnesses. Furthermore, if the patient dies during 
hospitalization or while seeking treatment, an autopsy may not necessarily be performed, 
and thus the true cause of death remains a mystery. Autopsy rates in the United States have 
been steadily declining since the 1970s, with 50% of autopsies now performed on persons 
whose death was related to an external cause, such as assault, suicide, and accidental 
poisoning.10 If a returning traveler (who truly had severe malaria) presented to an 
emergency department 2 weeks after returning from travel, a diagnosis of renal failure might 
be made based on creatinine levels. If no clues to the malaria infection were found and that 
patient subsequently died, his cause of death would be renal failure from unknown etiology. 
Although a routine autopsy would likely have identified the infection, with rates of hospital-
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based autopsy decreasing, the possibility of performing that autopsy is reduced. 
Additionally, factors such as time of death and autolysis may impair the ability to detect 
malaria through postmortem microscopy.11
Hargarten and colleagues analyzed overseas fatalities in US residents and found that only 
1% of overseas deaths were related to infectious disease, with one malaria-related death in 
the 2-year period of study.3 More than 5% of deaths analyzed were related to other or 
unknown causes.3 This analysis does not take into account deaths occurring in travelers 
returning home for care, which would likely have increased the number of deaths in the 
United States.
Surveillance of travel-related infectious diseases should be improved and expanded in ways 
that allow for capturing of travelers who present late with an illness as a result of infection 
acquired soon before returning or an extended asymptomatic period. Comprehensive travel 
status should be considered as part of a standard autopsy investigation.
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